SMS PHARMACEUTICALS LTD. - 532815 - Corporate Action-Board approves Dividend
Recommended the Dividend of Re.0.30 Paise (30%) per equity share of face value of Rs.1/-each for the financial year 2022-2324-05-2023
SMS PHARMACEUTICALS LTD. - 532815 - Corporate Action-Board approves Dividend
Recommended the Dividend of Re.0.30 Paise (30%) per equity share of face value of Rs.1/-each for the financial year 2022-23SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Independent DirectorSMS PHARMACEUTICALS LTD. - 532815 - Financial Results For The Fourth Quarter And Year Ended 31.03.2023
Outcome of Board Meeting and Financial ResultsSMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
Outcome of Board Meeting and Financial ResultsSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for 1.Approval Of Audited Financial Statements (Standalone & Consolidated) For The Fourth Quarter And Financial Year Ended 31St March, 2023. 2.Consider, Recommend Dividend If Any, For The Financial Year 2022-2023
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve 1. The Audited Financial Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2023. 2.To consider, recommend dividend if any, for the financial year 2022-2023SMS PHARMACEUTICALS LTD. - 532815 - Clarification On Price Movement
Clarification on Price MovementSMS PHARMACEUTICALS LTD. - 532815 - Clarification sought from SMS Pharmaceuticals Ltd
The Exchange has sought clarification from SMS Pharmaceuticals Ltd on April 25, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.SMS PHARMACEUTICALS LTD. - 532815 - Certificate Under Regulation 40(9)&(10) Of SEBI (LODR) Regulations, 2015, For 31St March, 2023
Compliance Certificate under Regulation 40(9)&(10) of SEBI (LODR) Regulations, 2015, for 31st March, 2023